Lab Pays $3.6 Million to Settle Allegedly Redundant Drug Tests
Clinical laboratory company Radeas, LLC has agreed to pay over $3.6 million to resolve allegations that it filed claims to the North Carolina Medicaid program for unnecessary urine drug tests.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.